A Ranbaxy Laboratories Ltd technician displays anti-anthrax Cipro tablets at their facility in Paonta Sahib in the northern Indian state of  Himachal Pradesh on Friday. The drug maker on Wednesday offered to supply the USA the anti-anthrax drugs, giving a glimpse of the strategy larger Indian drugmakers are now adopting— focus on the USA. —REUTERS